HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)

China · Delayed Price · Currency is CNY

11.29

+0.18 (1.62%)

Feb 3, 2026, 3:00 PM CST

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Wholesale - Medical Distribution	6.15B
Wholesale - Medical Distribution Growth	3.71%
Wholesale - Commercial Allocation	2.50B
Wholesale - Commercial Allocation Growth	17.14%
Chinese and Western Medicine	1.48B
Chinese and Western Medicine Growth	10.89%
Medical Equipment, Family Planning Supplies and Others	58.57M
Medical Equipment, Family Planning Supplies and Others Growth	3.10%
Other Business	40.70M
Other Business Growth	-5.57%
Health	36.63M
Health Growth	5.85%
Chinese Herbal Medicine	18.95M
Chinese Herbal Medicine Growth	1.27%
Daily Necessities	5.26M
Daily Necessities Growth	13.42%
Other	97.19M
Other Growth	18.69%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	10.39B
China Growth	7.77%